tiprankstipranks
Silence Therapeutics (SLN)
NASDAQ:SLN

Silence Therapeutics (SLN) Ownership - Who Owns Silence Therapeutics?

80 Followers

Silence Therapeutics (SLN) Ownership Overview

0.00%0.05%43.09%56.86%
0.00%
Insiders
43.09% Other Institutional Investors
56.86% Public Companies and
Individual Investors
The ownership structure of Silence Therapeutics (SLN) stock is a mix of institutional, retail and individual investors. Approximately 43.14% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 56.86% is owned by Public Companies and Individual Investors.
The ownership structure of Silence Therapeutics (SLN) stock is a mix of institutional, retail and individual investors. Approximately 43.14% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 56.86% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Sold$855854

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
49,272Institution0.11%1,047,030
22,427Institution0.05%476,574
19,387Institution0.04%411,974
5,374Institution0.01%114,198

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
22,427Institution0.05%476,574

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
19,593Institution0.04%404,791
5,374Institution0.01%111,027

FAQ

Who Owns Silence Therapeutics (SLN)?
According to the latest TipRanks data, approximately 43.09% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 56.86% is held by retail investors.
    What percentage of Silence Therapeutics (SLN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 43.09% of Silence Therapeutics (SLN) stock is held by institutional investors.
      What percentage of Silence Therapeutics (SLN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 56.86% of Silence Therapeutics (SLN) stock is held by retail investors.
        Who owns the most shares of Silence Therapeutics (SLN)?
        Michael Rockefeller owns the most shares of Silence Therapeutics (SLN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis